Point Break Capital Management’s Eli Lilly LLY Stock Holding History

Point Break Capital Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.36M	Sell	1,966 -953	-33%	-$974K	2.57%	12
2026 Q1	$2.68M	Sell	2,919 -893	-23%	-$905K	3.05%	9
2025 Q4	$4.1M	Buy	+3,812	New	+$3.64M	3.51%	12
2024 Q3	$3.74M	Sell	4,221 -180	-4%	-$162K	4.39%	7
2024 Q2	$3.98M	Buy	4,401 +2,000	+83%	+$1.6M	4.33%	5
2024 Q1	$1.87M	Buy	2,401 +1,036	+76%	+$737K	1.99%	9
2023 Q4	$796K	Buy	+1,365	New	+$797K	0.63%	8

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Point Break Capital Management's LLY Position: Q2 2026 in Review

Point Break Capital Management reduced its Eli Lilly (LLY) stake by 33% in Q2 2026, selling an estimated $974K and leaving 1,966 shares worth $2.36M. The position accounts for 2.57% of the portfolio, ranked #12.

Point Break Capital Management first reported a position in LLY in Q4 2023 and has held it in 7 quarters since. The position peaked at $4.1M in Q4 2025. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Point Break Capital Management held 1,966 shares of Eli Lilly worth $2.36M as of Q2 2026.
Point Break Capital Management sold 953 Eli Lilly shares in Q2 2026, an estimated $974K.
Eli Lilly made up 2.57% of Point Break Capital Management's portfolio in Q2 2026, its #12 holding.
Point Break Capital Management first reported a position in Eli Lilly in Q4 2023 and has held it in 7 quarters since.
Point Break Capital Management's Eli Lilly position peaked at $4.1M in Q4 2025.
4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Point Break Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.